Căutare | MTSocial

Harshasharma Harshasharma a adăugat un sunet Alte
2025-11-10 10:28:41 -

Trastuzumab Emtansine Market: A Precision Oncology Game-Changer on the Rise
The global trastuzumab emtansine market size was valued at USD 2.47 billion in 2024 and is expected to reach USD 4.78 billion by 2032, at a CAGR of 8.62% during the forecast period Introduction Trastuzumab emtansine is an antibody-drug conjugate (ADC) designed to deliver the cytotoxic agent DM1 (a maytansine derivative) to HER2-positive cancer cells via the...

0 Commentarii 0 Distribuiri 471 Views 0 previzualizare

Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
Harshasharma Harshasharma a adăugat un sunet Networking
2025-12-01 07:43:05 -

Trastuzumab Emtansine Market: A Precision Oncology Game-Changer on the Rise
Targeted drug conjugates are reshaping cancer therapy, and trastuzumab emtansine (T-DM1, Kadcyla) stands at the forefront by combining antibody specificity with cytotoxic potency.This market analysis delves into growing demand, regulatory shifts, emerging indications, and competitive dynamics in the trastuzumab emtansine landscape. Introduction Trastuzumab emtansine is an antibody-drug...

0 Commentarii 0 Distribuiri 254 Views 0 previzualizare

Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
Harshasharma Harshasharma a adăugat un sunet Alte
2025-10-30 08:51:15 -

Trastuzumab Emtansine Market: A Precision Oncology Game-Changer on the Rise
The global trastuzumab emtansine market size was valued at USD 2.47 billion in 2024 and is expected to reach USD 4.78 billion by 2032, at a CAGR of 8.62% during the forecast period Introduction Trastuzumab emtansine is an antibody-drug conjugate (ADC) designed to deliver the cytotoxic agent DM1 (a maytansine derivative) to HER2-positive cancer cells via the...

0 Commentarii 0 Distribuiri 615 Views 0 previzualizare

Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
Harshasharma Harshasharma a adăugat un sunet Alte
2025-10-15 09:09:41 -

Trastuzumab Emtansine Market: A Precision Oncology Game-Changer on the Rise
Targeted drug conjugates are reshaping cancer therapy, and trastuzumab emtansine (T-DM1, Kadcyla) stands at the forefront by combining antibody specificity with cytotoxic potency.This market analysis delves into growing demand, regulatory shifts, emerging indications, and competitive dynamics in the trastuzumab emtansine landscape. Introduction Trastuzumab emtansine is an antibody-drug...

0 Commentarii 0 Distribuiri 694 Views 0 previzualizare

Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!